46 results on '"Arat, Mutlu"'
Search Results
2. Allogeneic Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors for Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
3. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
4. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
5. Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)- the Role of Donor Kinship: From the ALWP of the EBMT
6. Non T–Cell Depleted Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
7. MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
8. Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia
9. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
10. Impact of an Established National Donor Registry on Transplant Outcome: Turkok Experience in Turkey
11. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
12. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
13. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party
14. Haploidentical Versus Unrelated Donor Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia: Single Center Experience
15. The Turkish experience with therapeutic plasma exchange: A national survey
16. Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients
17. Is There Any Room for Allogeneic Hematopoetic Stem Cell Transplantation in Relapse/Refractory Lymphoma: Single Center Experience
18. Should We Start Peripheral Blood Stem Cell Collection for Allogeneic Transplantation on the Fifth Day?
19. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)
20. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)
21. Peripheral blood stem cell collection for allogeneic hematopoietic stem cell transplantation: Practical implications after 200 consequent transplants
22. Allogenenic Hematopoetic Cell Transplantation in AML at CR1: Related vs Unrelated vs Haploidentical Donors
23. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
24. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates
25. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
26. Influence of Past Invasive Fungal Infections on Allogeneic Related Donor Hematopoietic Cell Transplantation Outcome in AML
27. Intramural Duodenal Haematoma After Upper Gastrointestinal Endoscopic Biopsy in a Bone Marrow Transplant Recipient
28. Selected papers from the 15th Congress of the Interdisciplinary European Society for Hemapheresis and Hemotherapy
29. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra
30. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight
31. Apheresis information management system (AMIS)
32. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases
33. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)
34. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates
35. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans
36. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure
37. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
38. Therapeutic plasma exchange in a single center: Ibni Sina experience
39. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy
40. Malpositioning of Hickman catheters, left versus right sided attempts
41. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange
42. Hematopoietic cell transplantation-related nephropathy
43. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation
44. National survey of hemapheresis practice in Turkey (1998)
45. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
46. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.